June 2024

Florida’s Drug Importation Plan Gains FDA Approval: What’s Next?

Innovations Magazine

Partner Libby Baney, director Elliot Vice, analyst Maya Bolter and senior manager Nisha Quasba co-authored an article for Innovations Magazine on the first ever Section 804 Importation Program (SIP) application approved by the FDA that aims to allow states to bulk import prescription drugs from Canada.

The article explores details of Florida’s SIP, including logistical details, anticipated timeline for implementation, and the program’s susceptibility to misinformation and misunderstanding. Despite challenges such as supply chain security risks, Florida’s approval not only sets a precedent for other states but also serves as a blueprint for future state applications. 

Full Article

Related Policy, Advocacy, and Consulting Services

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.